GSK seeks FDA approval for investigational HIV treatment
GlaxoSmithKline Plc said on Thursday its HIV unit has submitted a new drug application to the U.S. Food and Drug Administration seeking approval for fostemsavir, an experimental treatment for HIV in adults. [Source]
Publication Date:Origin: reuters.com
Category: companyNews
Topics: treatment, approval, adults, experimental, for fostemsavir, seeking, Administration, to the, application, submitted, on Thursday, GlaxoSmithKline, investigational, seeks